Prevalence of hepatic steatosis in patients with type 2 diabetes and response to glucose-lowering treatments. A multicenter retrospective study in Italian specialist care.

M L MorieriN VitturiA AvogaroG TargherGian Poalo Fadininull null

Published in: Journal of endocrinological investigation (2021)

About three quarters of patients with T2D have HSI values suggestive of MAFLD, a condition associated with macroangiopathy and nephropathy. Treatment with dapagliflozin or incretin therapies might improve MAFLD in T2D.

Keyphrases

palliative care
healthcare
risk factors
quality improvement
blood glucose
metabolic syndrome
adipose tissue
chronic pain
double blind
weight loss
smoking cessation